Ocugen Newsroom

Ocugen Is Maintained at Buy by Chardan Capital

Dow JonesNov 19 06:13

Ocugen Analyst Ratings

BenzingaNov 19 06:03

Maxim Group Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 16 01:31

H.C. Wainwright Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 14 19:33

Maxim Group Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $4

Futu NewsNov 13 00:32

Ocugen's Strong Financial Management and Promising Gene Therapy Pipeline Drive Buy Rating

TipRanksNov 11 19:31

H.C. Wainwright Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 11 19:31

Ocugen Analyst Ratings

BenzingaNov 9 08:12

Chardan Capital Maintains Buy on Ocugen, Maintains $6 Price Target

BenzingaNov 9 08:11

Maxim Group Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $4

Futu NewsOct 30 23:33

Ocugen Analyst Ratings

BenzingaOct 23 19:22

H.C. Wainwright Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 23 18:35

Ocugen Analyst Ratings

BenzingaOct 15 21:42

Maxim Group Initiates Ocugen(OCGN.US) With Buy Rating, Announces Target Price $4

Futu NewsOct 15 20:31

Ocugen (OCGN) Receives a Buy From Noble Financial

TipRanksAug 9 21:33

Buy Rating on Ocugen: Strong Financials and Promising Clinical Progress

TipRanksAug 9 19:19

Noble Financial Sticks to Their Buy Rating for Ocugen (OCGN)

TipRanksJul 26 20:39

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH) and Ocugen (OCGN)

TipRanksJul 26 20:39

Noble Financial Maintains Ocugen(OCGN.US) With Buy Rating, Maintains Target Price $8

Futu NewsJul 26 20:31

HC Wainwright & Co. : The Ocugen (OCGN.US) rating was reaffirmed and adjusted from buy to buy, and the target price was $7.00.

Zhitong FinanceMay 15 18:50